LP429468-4
Cariprazine
Active
Description
Cariprazine is one of the newest dopamine-serotonin partial agonists, also known as 'atypical' second generation antipsychotics. Originally approved for acute and maintenance treatment of schizophrenia as well as for acute mania and mixed mania/depression, cariprazine has now been approved for bipolar I depression. PMID: 32110377 Source: LOINC
Basic Part Properties
- Part Display Name
- Cariprazine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2021-09-03
- Construct for LOINC Short Name
- Cariprazine
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP429468-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP429468-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| it-IT | Italian (Italy) | Cariprazina |
| nl-NL | Dutch (Netherlands) | cariprazine |
| es-ES | Spanish (Spain) | Cariprazina |
| zh-CN | Chinese (China) | 卡比米嗪 Synonyms: CAS 839712-12-8; |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright